UPC Analytics
ENDE
Overview · Filed:

ACT_14945/2024

ANALYTE SENSOR DEVICES, CONNECTIONS, AND METHODS

Provisional measuresProvisional MeasuresThe Hague LDApplication for provisional measures
Parties

Claimants

Reps: Eelco Bergsma

Respondents

  • Sibio Technology Limited
  • Umedwings Netherlands B.V.
Reps: Thomas Gniadek
Judges
  • Edger BrinkmanPresiding judge, judge-rapporteur
  • Petri RinkinenLegally qualified judge
  • Margot KokkeLegally qualified judge
  • Renaud FulconisTechnically qualified judge
Patents
  • EP 3 831 283
CPC codes: A61B5/1451, H04L67/12, A61B5/15087, A61B5/145, A61B5/150022, A61B5/150335, A61B5/14503, A61B5/6849, A61B5/0004, A61B5/14532, A61B5/150503, A61B5/150877

Sector: Pharmaceutical & Medical

Outcome
PI denied
Filed:
First decided: Jun 19, 2024
Language:

Application for a preliminary injunction by Abbott Diabetes Care Inc. against Sibio Technology Limited and Umedwings Netherlands B.V. concerning EP 3 831 283 (wearable glucose monitoring device) was denied by The Hague Local Division. The court found it more likely than not that claim 1 of the patent would be held invalid for added matter (the claimed feature of a connector support being received through a distal-facing opening into a recess was not directly and unambiguously derivable from the application as filed). As a result, Abbott must bear defendants' costs. Value of the action set at EUR 4,000,000.